Johnson-Sirleaf Calls For Deepening Diagnostic Expertise, Health Systems

A former President of Liberia, Mrs Ellen Johnson-Sirleaf, says African countries must work to build research expertise in diseases affecting Africans and create better diagnostics, drugs, vaccines and medical devices in Africa.

Johnson-Sirleaf said this recently during the CelebrateLAB West Africa Conference in Accra, Ghana, and monitored virtually by the News Agency of Nigeria.

CelebrateLAB Conference is an annual meeting of medical laboratory and research professionals, regulators, policy makers, academia and medical product manufacturers and suppliers.

The conference seeks to proffer solutions to enhance laboratory capacity in the area of human resources, clinical research, vaccines and other medical products manufacturing in West Africa.

The theme of the conference is, “Ensuring Diagnostic Capability and Vaccine Sufficiency as Panacea to Combating Infectious Diseases in West Africa”.

Johnson-Sirleaf noted that enhancing expertise in laboratory science and infrastructure development would assist in building robust health systems.

According to her, West Africa for a while has been battling with one infectious disease after the other, and the region has faced Marburg Virus, Lassa Fever and Dengue Fever.

“We have experienced the devastating effects of the Ebola Virus Disease that destroyed lives and livelihoods in Guinea, Sierra Leone and in my own country, Liberia.

“As President of Liberia, I witnessed at first hand the devastating effects of the infectious disease on the lives of our people and their livelihoods when the Ebola crisis hit our subregion in 2014.

“We saw how the gaps in our healthcare systems are directly linked to our economies. We saw how inadequate medical laboratories and professional expertise dictated our response to the crisis.

“We knew that if we had adequate surveillance mechanisms, the expertise and knowledge in the analysis of emerging infectious disease agents in the subregion and the technology and the capacity to diagnose Ebola cases faster, we could have provided timely treatment and perhaps, saved a lot more lives than we did,” the former president said.

Johnson-Sirleaf said that it took huge determination to beat Ebola in Liberia and other parts of the subregion and to begin to build resilience for the future.

She noted that currently, the  subregion was experiencing the impact of COVID-19 pandemic that had further worsened the plight of economies and brought hardship to the people.

According to her, gaps experienced in the subregion during the Ebola crisis continued to exist when the initial cases of COVID-19 were recorded on the continent.

She listed the gaps faced at the onset of the pandemic to include lack of personal protection equipment, testing kits, medical devices, modern diagnostic infrastructure and limited expertise.

She, however, said that in spite of the challenges, the subregion, and indeed, Africa, through determination and resilience had done well managing the current pandemic.

Johnson-Sirleaf recognised and celebrated the role played by African medical laboratory scientists in diagnosing and surveillance that assisted in combating COVID-19 disease.

The former president called on all managers of healthcare systems and health ministries across West Africa to recognise and respect the important contribution of medical laboratory and research professionals in their quest to ensure a healthier continent.

She stressed the need to improve diagnostic capacity of diseases, especially infectious disease and strengthening laboratory environment by applying the lessons learnt from the COVID-19 pandemic and previous outbreaks

Johnson-Sirleaf called for collaboration to enhance the capacity of medical laboratory professionals to meet global standards and be equipped with the necessary logistics and resources to aid them in their work.

She advised strengthening health and collaborative research in the region to  ensure that citizens have equitable access to healthcare, and a health system ready to combat any outbreak.

Also, Mr Kwaku Agyemang-Manu, Minister of Health, Ghana, said Africa and the West Africa subregion must work toward attaining vaccine sufficiency through production.

Agyemang-Manu said that the current system in which securing access to vaccines was based on advance purchase agreements, incentives of intellectual property, production capacity and competition was not sustainable.

He said that in addressing those challenges, the Ghanaian government had established a Vaccine Production Committee and gotten approval of the Cabinet to establish a Vaccine Institute.

The minister said that the country partnered with Senegal and Rwanda in its vaccine sufficiency agenda.

“With 25 million dollars from the Government of Ghana as seed money, funding support of five million euros from the German Development Cooperation and support from other Development Partners has been secured to take the process forward,” he said.

He said that the private sector-led consortium plant was expected to be fully operational by January 2024 to produce the country’s first COVID-19 vaccines.

Agyemang-Manu noted that it was part of a 10-year road map to make Ghana self-sufficient in vaccine production, not only COVID-19 vaccines, and to meet national and regional needs


Discover more from LN247

Subscribe to get the latest posts sent to your email.

Advertisement

Most Popular This Week

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More from Author

Advertisement

Read Now

Trump Presidency: How US withdrawal from WHO might impact global health

On his first day back in the Oval Office, President Donald Trump reignited a decision: withdrawing the United States from the World Health Organization (WHO). The move, which mirrors his actions during his first term, has sparked concerns among scientists, health experts, and global leaders about its...

FG Strengthens Efforts To Tackle Food Export Challenges

The Federal Government has taken steps to address challenges in food export regulations through a partnership between the Ministry of Industry, Trade and Investment and the Ministry of Health and Social Welfare. The collaboration also aims to unlock the healthcare value chain for transformative growth. The Minister of...

Human Metapneumovirus (HMPV): What You Need to Know

Human Metapneumovirus (HMPV) is a relatively unknown but increasingly significant respiratory virus that has caught the attention of global health experts. Since its discovery in 2001, it has become one of the leading causes of respiratory illnesses, especially in young children, the elderly, and individuals with compromised...

Discover more from LN247

Subscribe now to keep reading and get access to the full archive.

Continue reading